Federal contract award
75A50124F61010
THE PURPOSE OF THIS TASK ORDER IS TO PROCURE STORAGE AND STABILITY FOR ANTIGENS AND ADJUVANTS FROM PRIOR CONTRACTS FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ 75A50122D000002 DURING BASE PERIOD YR. 3. PERIOD OF PERFORMANCE: FEBRUARY
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN14 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES |
| Parent award / vehicle | 75A50122D00002 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $7.8M |
| Current contract value | $7.8M |
| Potential contract value / ceiling | $7.8M |
| Start date | Feb 21, 2024 |
| Current end date | May 21, 2027 |
| Potential end date | May 21, 2027 |
| Latest award activity | Mar 31, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 31, 2026 | P00009 | $2.7M | THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/202 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ 75A50122D00002. |
| Nov 20, 2025 | P00008 | $16.2K | THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/202 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ 75A50122D00002. |
| Sep 17, 2025 | P00007 | $24.4K | THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/202 ( H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ 75A50122D00002. |
| Jun 24, 2025 | P00006 | $15.3K | THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/202 ( H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ 75A50122D00002. |
| May 6, 2025 | P00005 | $2.2M | THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/202 ( H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ 75A50122D00002. |
| Feb 19, 2025 | P00004 | $0 | THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/202 ( H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ 75A50122D00002. THE TOTAL AMOUNT, SCOPE, AND ALL OTHER TERMS |
| Aug 12, 2024 | P00003 | $0 | THE PURPOSE OF THIS ADMINISTRATIVE MODIFICATION IS TO UPDATE ARTICLE G.2. CONTRACTING OFFICER'S REPRESENTATIVE (COR). BEZA SEYOUM REPLACES LAKSHMI JAYASHANKAR AS THE CONTRACTING OFFICE REPRESENTATIVE (COR) EMAIL ADDRESS IS BEZA.SEYOUM@HHS.GOV PH |
| May 31, 2024 | P00002 | $0 | THIS MODIFICATION ACKNOWLEDGES THE RECEIPT OF 133,835 ADJUVANT VIALS FROM CONTRACT HHSO100201500010C TO 75A50122D00002/75A50124F61010- CLIN 0007E. |
| Apr 22, 2024 | P00001 | $2.3M | THE PURPOSE OF THIS MODIFICATION IS TO REFLECT THE FOLLOWING: 1. EXECUTE FAR 52.217-9 "OPTION TO EXTEND THE TERM OF THE CONTRACT" EXERCISING OPTION PERIOD 1. OPTION PERIOD 1'S PERIOD OF PERFORMANCE IS 5/22/2024-5/21/2025. 2. |
| Feb 20, 2024 | 0 | $568.2K | THE PURPOSE OF THIS TASK ORDER IS TO PROCURE STORAGE AND STABILITY FOR ANTIGENS AND ADJUVANTS FROM PRIOR CONTRACTS FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ 75A50122D000002 DURING BASE PERIOD YR. 3. PERIOD OF PERFORMANCE: FEBRUARY |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
75/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 75/100. Available recorded signals: 70 points.
- Contract end 2027-05-21 (208 days from calculation)
- +35 points
- 9 historical awards in this buyer and category group
- +15 points
- 10 recorded award transactions
- +10 points
- Latest award action: 2026-03-31
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.